European Leukemia Trial Registry
Trial: ST Moxifloxacin in prophylaxis of bacteraemia

More Details
Title Efficacy and safety of Moxifloxacin in prophylaxis of bacteraemia after high dose chemotherapy and transplantation peripheral stem cells
Short Title ST Moxifloxacin in prophylaxis of bacteraemia
Trialgroup AGIHO
Type of Trial monocentic
Disease Miscellaneous(Miscellaneous) Supportive Care
Age <= 75 years
Status Closed
Start of Recruitment 10.10.2006
Leader Cornely, Prof. Dr., Oliver A.
Centre of Trial Universitätsklinikum der Universität zu Köln
Shortprotocol Shortprotocol
created 06.11.2008 5 Roswitha Kotthoff
changed 13.11.2014 Alexandra Lucaciu
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org